C - Chemistry – Metallurgy – 07 – H
Patent
C - Chemistry, Metallurgy
07
H
C07H 21/00 (2006.01) A61K 31/70 (2006.01) C07J 43/00 (2006.01) C12N 15/11 (2006.01)
Patent
CA 2199464
Disclosed is an oligonucleotide prodrug comprising at least six covalently linked nucleotides, at least one of which is derivatized with a lipophilic chemical group reversibly and covalently attached to the nucleotide at a 5' phosphate, a 3' phosphate, or an internucleotidic phosphate linkage. The prodrug is reactive with a cellular or tissue enzyme which cleaves the lipophilic group from the derivatized nucleotide, thereby regenerating the parent oligonucleotide.
L'invention concerne un promédicament oligonucléotidique comprenant au moins six nucléotides à liaison covalente, dont au moins un est dérivé avec un groupe chimique lipophile fixé de manière réversible et covalente au nucléotide au niveau d'un phosphate 5', d'un phosphate 3', ou d'une liaison phosphate internucléotidique. Le promédicament réagit avec une enzyme cellulaire ou tissulaire qui clive le groupe lipophile du nucléotide dérivé, ce qui régénère l'oligonucléotide parent.
Agrawal Sudhir
Devlin Theresa
Iyer Radhakrishnan
Yu Dong
Hybridon Inc.
Mbm & Co.
LandOfFree
Oligonucleotide prodrugs does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oligonucleotide prodrugs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oligonucleotide prodrugs will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1549822